The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature)
Open accessAbstract
Lung cancer is one of the most common malignant cancers in most countries and is the leading cause of death among cancer diseases worldwide. Despite constant progress in diagnosis and therapy, survival rates of patients diagnosed with lung cancer remain unsatisfactory. Numerous epidemiological and experimental studies conducted as early as the 1970s confirm that the most important risk factor for the development of lung cancer is long-term smoking, which remains valid to this day. In the paper, the authors present the latest data on the epidemiology, pathogenesis, treatment and molecular aspects of this cancer. In the last decade, many molecular alterations that are effective in the development of lung cancer have been discovered. In adenocarcinoma, tyrosine kinase inhibitors were developed for EGFR mutations and ALK and ROS1 translocations and were approved for use in the treatment of advanced stage adenocarcinomas. In the case of squamous cell carcinoma, the evaluation of these mutations is not yet being used in clinical practice. In addition, there are ongoing studies concerning many potential therapeutic molecular targets, such as ROS, MET, FGFR, DDR-2 and RET. Constant progress in diagnostic and therapeutic methods gives rise to hopes for an improved prognosis in patients with lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Goldstraw, P., Chansky, K., Crowley, J., Rami-Porta, R., Asamura, H., Eberhardt, W. E. E., Nicholson, A. G., Groome, P., Mitchell, A., Bolejack, V., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.09.009 · Cited by 4,607
Scagliotti, G. V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., Serwatowski, P., Gatzemeier, U., Digumarti, R., Zukin, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0375 · Cited by 3,203
VEGF in signaling and disease: beyond discovery and development
Apte, R. S., Chen, D. S., & Ferrara, N. (2019) · Cell · doi:10.1016/j.cell.2019.01.021 · Cited by 2,721
Lung Cancer: Epidemiology, Etiology, and Prevention
Dela Cruz, C. S., Tanoue, L. T., & Matthay, R. A. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.09.001 · Cited by 2,484
Bade, B. C., & Dela Cruz, C. S. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.10.001 · Cited by 1,911
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Yi, M., Zheng, X., Niu, M., Zhu, S., Ge, H., & Wu, K. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01489-2 · Cited by 1,445
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., D’Amico, T. A., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0025 · Cited by 1,392
Brierley, J. D., Gospodarowicz, M. K., & Wittekind, C. (2017) · TNM Online · doi:10.1002/9780471420194.tnmc26.pub3 · Cited by 1,231
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Wakelee, H., Liberman, M., Kato, T., Tsuboi, M., Lee, S.-H., Gao, S., Chen, K.-N., Dooms, C., Majem, M., Eigendorff, E., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2302983 · Cited by 1,180
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Jayasankar, N., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,062
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., D’Amico, T. A., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0013 · Cited by 948
Chaitanya Thandra, K., Barsouk, A., Saginala, K., Sukumar Aluru, J., & Barsouk, A. (2021) · Współczesna Onkologia · doi:10.5114/wo.2021.103829 · Cited by 890
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
The epidemiology of lung cancer
de Groot, P. M., Wu, C. C., Carter, B. W., & Munden, R. F. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.05.06 · Cited by 716
Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.12.001 · Cited by 645
The emerging clinical relevance of genomics in cancer medicine
Berger, M. F., & Mardis, E. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0002-6 · Cited by 626
Strzelak, A., Ratajczak, A., Adamiec, A., & Feleszko, W. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15051033 · Cited by 619
Ardizzoni, A., Boni, L., Tiseo, M., Fossella, F. V., Schiller, J. H., Paesmans, M., Radosavljevic, D., Paccagnella, A., Zatloukal, P., Mazzanti, P., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk196 · Cited by 612
Moreira, A. L., Ocampo, P. S. S., Xia, Y., Zhong, H., Russell, P. A., Minami, Y., Cooper, W. A., Yoshida, A., Bubendorf, L., Papotti, M., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.06.001 · Cited by 559
Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?
Qiu, F., Liang, C.-L., Liu, H., Zeng, Y.-Q., Hou, S., Huang, S., Lai, X., & Dai, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.13613 · Cited by 554
Jackman, D. M., & Johnson, B. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67569-1 · Cited by 503
Kalemkerian, G. P., Narula, N., Kennedy, E. B., Biermann, W. A., Donington, J., Leighl, N. B., Lew, M., Pantelas, J., Ramalingam, S. S., Reck, M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.7293 · Cited by 492
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
KONTOMANOLIS, E. N., KOUTRAS, A., SYLLAIOS, A., SCHIZAS, D., MASTORAKI, A., GARMPIS, N., DIAKOSAVVAS, M., ANGELOU, K., TSATSARIS, G., PAGKALOS, A., et al. (2020) · Anticancer Research · doi:10.21873/anticanres.14622 · Cited by 389
Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer
Chaft, J. E., Rimner, A., Weder, W., Azzoli, C. G., Kris, M. G., & Cascone, T. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00501-4 · Cited by 375
Auscultation of the respiratory system
Sarkar, M., Madabhavi, I., Niranjan, N., & Dogra, M. (2015) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.160831 · Cited by 362
Five-Year Survival in EGFR -Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs
Lin, J. J., Cardarella, S., Lydon, C. A., Dahlberg, S. E., Jackman, D. M., Jänne, P. A., & Johnson, B. E. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.12.103 · Cited by 356
Ferguson, L. R., Chen, H., Collins, A. R., Connell, M., Damia, G., Dasgupta, S., Malhotra, M., Meeker, A. K., Amedei, A., Amin, A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.005 · Cited by 336
Proctor, R. N. (2012) · Tobacco Control · doi:10.1136/tobaccocontrol-2011-050338 · Cited by 333
Loomis, D., Huang, W., & Chen, G. (2014) · Chinese Journal of Cancer · doi:10.5732/cjc.014.10028 · Cited by 328
Epigenetic drivers of tumourigenesis and cancer metastasis
Chatterjee, A., Rodger, E. J., & Eccles, M. R. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.004 · Cited by 328
Pinsky, P. F., Church, T. R., Izmirlian, G., & Kramer, B. S. (2013) · Cancer · doi:10.1002/cncr.28326 · Cited by 293
Polycyclic aromatic hydrocarbons and PAH-related DNA adducts
Ewa, B., & Danuta, M.-Š. (2017) · Journal of Applied Genetics · doi:10.1007/s13353-016-0380-3 · Cited by 278
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects
Tang, S., Qin, C., Hu, H., Liu, T., He, Y., Guo, H., Yan, H., Zhang, J., Tang, S., & Zhou, H. (2022) · Cells · doi:10.3390/cells11030320 · Cited by 256
Molecular Biology of Lung Cancer
Nana-Sinkam, S. P., & Powell, C. A. (2013) · Chest · doi:10.1378/chest.12-2346 · Cited by 248
Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study
Tindle, H. A., Stevenson Duncan, M., Greevy, R. A., Vasan, R. S., Kundu, S., Massion, P. P., & Freiberg, M. S. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy041 · Cited by 208
Tobacco and Lung Cancer: Risks, Trends, and Outcomes in Patients with Cancer
Warren, G. W., & Cummings, K. M. (2013) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbook_am.2013.33.359 · Cited by 206
Radon and Lung Cancer: Current Trends and Future Perspectives
Riudavets, M., Garcia de Herreros, M., Besse, B., & Mezquita, L. (2022) · Cancers · doi:10.3390/cancers14133142 · Cited by 206
Jha, P. (2020) · eLife · doi:10.7554/elife.49979 · Cited by 189
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
Mintz, J., Vedenko, A., Rosete, O., Shah, K., Goldstein, G., Hare, J. M., Ramasamy, R., & Arora, H. (2021) · Vaccines · doi:10.3390/vaccines9020094 · Cited by 180
Environmental and occupational determinants of lung cancer
Shankar, A., Dubey, A., Saini, D., Singh, M., Prasad, C. P., Roy, S., Bharati, S. J., Rinki, M., Singh, N., Seth, T., et al. (2019) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.03.05 · Cited by 176
Current treatments for non-small cell lung cancer
Guo, Q., Liu, L., Chen, Z., Fan, Y., Zhou, Y., Yuan, Z., & Zhang, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.945102 · Cited by 171
Oncogenes and tumor suppressor genes: functions and roles in cancers
Dakal, T. C., Dhabhai, B., Pant, A., Moar, K., Chaudhary, K., Yadav, V., Ranga, V., Sharma, N. K., Kumar, A., Maurya, P. K., et al. (2024) · MedComm · doi:10.1002/mco2.582 · Cited by 170
Ohshimo, S., Guzman, J., Costabel, U., & Bonella, F. (2017) · European Respiratory Review · doi:10.1183/16000617.0012-2017 · Cited by 169
Role and targeting of anaplastic lymphoma kinase in cancer
Corte, C. M. D., Viscardi, G., Liello, R. D., Fasano, M., Martinelli, E., Troiani, T., Ciardiello, F., & Morgillo, F. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0776-2 · Cited by 155
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
Šutić, M., Vukić, A., Baranašić, J., Försti, A., Džubur, F., Samaržija, M., Jakopović, M., Brčić, L., & Knežević, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111102 · Cited by 150
Facchinetti, F., Mazzaschi, G., Barbieri, F., Passiglia, F., Mazzoni, F., Berardi, R., Proto, C., Cecere, F. L., Pilotto, S., Scotti, V., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.02.023 · Cited by 149
Advances in lung cancer screening and early detection
Li, C., Wang, H., Jiang, Y., Fu, W., Liu, X., Zhong, R., Cheng, B., Zhu, F., Xiang, Y., He, J., et al. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0690 · Cited by 148
The Evolution of Therapies in Non-Small Cell Lung Cancer
Boolell, V., Alamgeer, M., Watkins, D. N., & Ganju, V. (2015) · Cancers · doi:10.3390/cancers7030864 · Cited by 141
Rota, M., Bosetti, C., Boccia, S., Boffetta, P., & Vecchia, C. L. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1296-5 · Cited by 133
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options
Petrella, F., Rizzo, S., Attili, I., Passaro, A., Zilli, T., Martucci, F., Bonomo, L. D., Grande, F. D., Casiraghi, M., de Marinis, F., et al. (2023) · Current Oncology · doi:10.3390/curroncol30030239 · Cited by 124
Arsenic, asbestos and radon: emerging players in lung tumorigenesis
Hubaux, R., Becker‐Santos, D. D., Enfield, K. S. S., Lam, S. C., Lam, W. L., & Martínez, V. D. (2012) · Environmental Health · doi:10.1186/1476-069x-11-89 · Cited by 117
Comprehensive characterization of mainstream marijuana and tobacco smoke
Graves, B., Johnson, T. J., Nishida, R. T., Dias, R. P., Savareear, B., Harynuk, J. J., Kazemimanesh, M., Olfert, J. S., & Boies, A. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-63120-6 · Cited by 115
Gilham, C., Rake, C., Burdett, G., Nicholson, A. G., Davison, L., Franchini, A., Carpenter, J. R., Hodgson, J. T., Darnton, A., & Peto, J. (2015) · Occupational and Environmental Medicine · doi:10.1136/oemed-2015-103074 · Cited by 114
Time for a smoke? One cigarette reduces your life by 11 minutes
Shaw, M., Mitchell, R., & Dorling, D. (2000) · BMJ · doi:10.1136/bmj.320.7226.53 · Cited by 113
E-Cigarettes and Associated Health Risks: An Update on Cancer Potential
Sahu, R., Shah, K., Malviya, R., Paliwal, D., Sagar, S. R., Singh, S. K., Prajapati, B. G., & Bhattacharya, S. (2023) · Advances in respiratory medicine · doi:10.3390/arm91060038 · Cited by 102
The molecular basis of lung cancer: molecular abnormalities and therapeutic implications
Massion, P. P., & Carbone, D. P. (2003) · Respiratory Research · doi:10.1186/1465-9921-4-12 · Cited by 99
Recent Studies on DNA Adducts Resulting from Human Exposure to Tobacco Smoke
Ma, B., Stepanov, I. S., & Hecht, S. S. (2019) · Toxics · doi:10.3390/toxics7010016 · Cited by 95
Surveillance for Cancers Associated with Tobacco Use — United States, 2010–2014
Gallaway, M. S., Henley, S. J., Steele, C. B., Momin, B. R., Thomas, C. C., Jamal, A., Trivers, K. F., Singh, S. D., & Stewart, S. L. (2018) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6712a1 · Cited by 94
Biomarkers and Lung Cancer Early Detection: State of the Art
Dama, E., Colangelo, T., Fina, E., Cremonesi, M., Kallikourdis, M., Veronesi, G., & Bianchi, F. (2021) · Cancers · doi:10.3390/cancers13153919 · Cited by 94
Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions
Garg, P., Singhal, S., Kulkarni, P., Horne, D. A., Malhotra, J. D., Salgia, R., & Singhal, S. S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144189 · Cited by 94
BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective
Yan, N., Guo, S., Zhang, H., Zhang, Z., Shen, S., & Li, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.863043 · Cited by 87
Rémen, T., Pintos, J., Abrahamowicz, M., & Siemiatycki, J. (2018) · BMC Cancer · doi:10.1186/s12885-018-5144-5 · Cited by 86
Lung Cancer and Radiological Imaging
Panunzio, A., & Sartori, P. (2020) · Current Radiopharmaceuticals · doi:10.2174/1874471013666200523161849 · Cited by 82
Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation
Amicizia, D., Piazza, M. F., Marchini, F., Astengo, M., Grammatico, F., Battaglini, A., Schenone, I., Sticchi, C., Lavieri, R., Silverio, B. D., et al. (2023) · Healthcare · doi:10.3390/healthcare11142085 · Cited by 76
Du, Y., Cui, X., Sidorenkov, G., Groen, H. J. M., Vliegenthart, R., Heuvelmans, M. A., Liu, S., Oudkerk, M., & de Bock, G. H. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr.2020.02.11 · Cited by 73
Wang, A., Kubo, J. T., Luo, J., Desai, M., Hedlin, H., Henderson, M. A., Chlebowski, R. T., Tindle, H., Chen, C., Gomez, S. L., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu470 · Cited by 70
Ang, L., Chan, C. P. Y., Yau, W., & Seow, W. J. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.08.012 · Cited by 65
Functional validity, role, and implications of heavy alcohol consumption genetic loci
Thompson, A., Cook, J. P., Choquet, H., Jorgenson, E., Yin, J., Kinnunen, T. K., Barclay, J. W., Morris, A. P., & Pirmohamed, M. (2020) · Science Advances · doi:10.1126/sciadv.aay5034 · Cited by 64
Socinski, M. A., Özgüroğlu, M., Villegas, A. E., Daniel, D. B., Vicente, D., Murakami, S., Hui, R., Gray, J. E., Park, K., Vincent, M. D., et al. (2021) · Clinical Lung Cancer · doi:10.1016/j.cllc.2021.05.009 · Cited by 64
Epigenetic mechanisms in metal carcinogenesis
Manić, L., Wallace, D., Onganer, P. U., Taalab, Y. M., Farooqı, A. A., Antonijević, B., & Djordjević, A. B. (2022) · Toxicology Reports · doi:10.1016/j.toxrep.2022.03.037 · Cited by 62
Provencio, M., Calvo, V., Romero, A., Spicer, J. D., & Cruz‐Bermúdez, A. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_358995 · Cited by 62
Xu, Z., & Li, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s194870 · Cited by 60
Noia, V. D., D’Aveni, A., D’Argento, E., Rossi, S., Ghirardelli, P., Bortolotti, L., Vavassori, V., Bria, E., & Ceresoli, G. L. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100280 · Cited by 60
Malignant Superior Vena Cava Syndrome: A Scoping Review
Wright, K., Digby, G. C., Gyawali, B., Jad, R., Ménard, A., de Moraes, F. Y., & Wijeratne, D. T. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.04.019 · Cited by 59
Diagnosis and management of peripheral lung nodule
Khan, T., Usman, Y., Abdo, T., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.03.59 · Cited by 57
The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions
Rina, A., Maffeo, D., Minnai, F., Esposito, M., Palmieri, M., Serio, V. B., Rosati, D., Mari, F., Frullanti, E., & Colombo, F. (2024) · Cancers · doi:10.3390/cancers16162882 · Cited by 57
Insa, A., Martín-Martorell, P., Liello, R. D., Fasano, M., Martini, G., Napolitano, S., Vicidomini, G., Cappabianca, S., Franco, R., Morgillo, F., et al. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103538 · Cited by 47
Comella, P., Filippelli, G., Cataldis, G. D., Massidda, B., Frasci, G., Maiorino, L., Putzu, C., Mancarella, S., PALMERI, S., Cioffi, R., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl396 · Cited by 46
Breathing new insights into the role of mutant p53 in lung cancer
Chen, T., Ashwood, L. M., Kondrashova, O., Strasser, A., Kelly, G., & Sutherland, K. D. (2025) · Oncogene · doi:10.1038/s41388-024-03219-6 · Cited by 46
The Benefits of Quitting Smoking at Different Ages
Le, T. T., Méndez, D., & Warner, K. E. (2024) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2024.06.020 · Cited by 45
Role of Chemotherapy and Targeted Therapy in Early-Stage Non–Small Cell Lung Cancer
Gadgeel, S. M. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175188 · Cited by 44
Zhou, C., Qin, Y., Zhao, W. M., Liang, Z., Li, M., Liu, D., Bai, L., Chen, Y., Chen, Y., Cheng, Y. S., et al. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-23-339 · Cited by 44
Figueiredo, V. R., Cardoso, P. F. G., Jacomelli, M., Santos, L. M., Minata, M. K., & Terra, R. M. (2020) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20190221 · Cited by 43
International consensus on radiotherapy in metastatic non-small cell lung cancer
Zhu, Z., Ni, J., Cai, X., Su, S., Zhuang, H., Yang, Z., Chen, M., Ma, S., Xie, C., Xu, Y., et al. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-644 · Cited by 42
Sirohi, B., Ashley, S. E., Norton, A., et al. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31811f3a7d · Cited by 40
Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors
Brindel, A., Althakfi, W., Barritault, M., Watkin, E., Maury, J., Bringuier, P., Girard, N., & Brevet, M. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-19-3790 · Cited by 40
Lin, Y., Yu, C., Yang, J. C., & Shih, J. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.03.005 · Cited by 39
Reduced life expectancy due to smoking in large-scale cohort studies in Japan.
Ozasa, K., Katanoda, K., Tamakoshi, A., Sato, H., Tajima, K., Suzuki, T., Tsugane, S., & Sobue, T. (2008) · Journal of Epidemiology · doi:10.2188/jea.je2007416 · Cited by 36
Approach to Imaging of Mediastinal Masses
Ahuja, J., Strange, C. D., Agrawal, R., Erasmus, L. T., & Truong, M. T. (2023) · Diagnostics · doi:10.3390/diagnostics13203171 · Cited by 36
Cui, J., Li, W., Han, F., & Liu, Y. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2015.02.05 · Cited by 35
Chronic Pericardial Effusion: Causes and Management
Lazaros, G. A., Imazio, M., Tsioufis, P., Lazarou, E., Vlachopoulos, C. V., & Tsioufis, C. P. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.02.003 · Cited by 33
Rate of Pathogenic Germline Variants in Patients With Lung Cancer
Sorscher, S. M., LoPiccolo, J., Heald, B., Chen, E. Y., Bristow, S. L., Michalski, S. T., Nielsen, S. M., Lacoste, A. M. B., Keyder, E., Lee, H., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.23.00190 · Cited by 33
Anti-PD-1 And Anti-PD-L1 Antibodies as Immunotherapy Against Cancer: A Structural Perspective
Córdova-Bahena, L., & Velasco-Velázquez, M. A. (2020) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.20000341 · Cited by 32
Advancements of ALK inhibition of non-small cell lung cancer: a literature review
Zia, V. A. D. A., Lengyel, C. G., Tajima, C. C., & de Mello, R. A. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-619 · Cited by 32
Lung cancer related to occupational exposure: an integrative review
Brey, C., Gouveia, F. T., Silva, B. S., Sarquis, L. M. M., Miranda, F. M. D., & Consonni, D. (2020) · Revista gaúcha de enfermagem · doi:10.1590/1983-1447.2020.20190378 · Cited by 29
New developments in the imaging of lung cancer
T�rnoki, �. D., T�rnoki, D. L., Dąbrowska, M., Knetki‐Wróblewska, M., Frille, A., Stubbs, H., Blyth, K. G., & Juul, A. D. (2024) · Breathe · doi:10.1183/20734735.0176-2023 · Cited by 29
Food, Nutrition, Physical Activity and Microbiota: Which Impact on Lung Cancer?
Nigro, E., Perrotta, F., Scialò, F., D’Agnano, V., Mallardo, M., Bianco, A., & Daniele, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052399 · Cited by 27
The Early Diagnosis of Lung Cancer: Critical Gaps in the Discovery of Biomarkers
Gasparri, R., Sabalic, A., & Spaggiari, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237244 · Cited by 27
Molecular Pathology of Lung Cancer: Current Status and Future Directions
Roh, M. S. (2014) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2014.77.2.49 · Cited by 26
Wislez, M., Leprieur, E. G., Fallet, V., & Cadranel, J. L. (2016) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s99303 · Cited by 25
Lung cancer cytology: Can any of the cytological methods replace histopathology?
Chrabańska, M., Środa, M., Kiczmer, P., & Drozdzowska, B. (2020) · Journal of Cytology · doi:10.4103/joc.joc_168_19 · Cited by 25
PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms
Akay, S., Pollard, J. H., Eddin, A. S., Alatoum, A., Kandemirli, S. G., Gholamrezanezhad, A., Menda, Y., Graham, M. M., & Shariftabrizi, A. (2023) · Cancers · doi:10.3390/cancers15153759 · Cited by 24
Takahashi, T., Sakai, K., Kenmotsu, H., Yoh, K., Daga, H., Ohira, T., Ueno, T., Aoki, T., Hayashi, H., Yamazaki, K., et al. (2021) · Cancer Science · doi:10.1111/cas.15171 · Cited by 23
Advanced surgical technologies for lung cancer treatment: Current status and perspectives
Cai, H., Wang, Y., Qin, D., Cui, Y., & Zhang, H. (2022) · Engineered Regeneration · doi:10.1016/j.engreg.2022.12.001 · Cited by 23
Xu, Y., Chang, H., Wu, L., Zhang, X., Zhang, L., Zhang, J., Li, Y., Shen, L., Zhu, X., Zhou, X., et al. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104548 · Cited by 19
Lai, Y.-C., Wu, K.-C., Tseng, N.-C., Chen, Y.-J., Chang, C.-J., Yen, K., & Kao, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.773041 · Cited by 19
Current status of molecular diagnostics for lung cancer
Имянитов, Е. Н., Преображенская, Е. В., & Орлов, С. В. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00244 · Cited by 18
Bi, H., Ren, D., Ding, X., Yin, X., Cui, S., Guo, C., & Wang, H. (2020) · Translational Cancer Research · doi:10.21037/tcr-20-1813 · Cited by 15
Chen, W., Chen, J., Zhang, L., Cheng, S., & Yu, J. (2023) · BMC Cancer · doi:10.1186/s12885-023-11285-4 · Cited by 14
Moretti, A., Kovacevic, B., Vilmann, P., Annema, J. T., & Korevaar, D. A. (2023) · Lung Cancer · doi:10.1016/j.lungcan.2023.107391 · Cited by 14
Induction treatment in patients with stage III non-small cell lung cancer
Palmero, R., Vilariño, N., Navarro-Martín, A., & Nadal, E. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-420 · Cited by 13
Borrell, L. N., & Echeverría, S. E. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102742 · Cited by 13
The role of plasma genotyping in ALK- and ROS1-rearranged lung cancer
Dagogo‐Jack, I., & Ritterhouse, L. L. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-2019-cnsclc-09 · Cited by 12
PACIFIC trial: new perspectives for immunotherapy in lung cancer
Agustoni, F., & Hirsch, F. R. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.12.12 · Cited by 8
Helal, A. A., Kamal, I. H., Osman, A., Youssef, M., & Ibrahim, A. K. (2024) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-024-00251-1 · Cited by 7
Alrasheedi, M., Han, S., Thygesen, H., Neilson, M., Hendry, F., Alkarn, A., Maclay, J., & Leung, H. (2023) · Diagnostics · doi:10.3390/diagnostics13071209 · Cited by 6
Pericardial effusions: perspective of the acute cardiac care physician
Jain, C. C., & Reddy, Y. N. V. (2023) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad050 · Cited by 6
Chmielewska, I., Krawczyk, P., Wójcik-Superczyńska, M., Grenda, A., Gil, M., Stencel, K. M., Kieszko, R., Jankowski, T., & Milanowski, J. (2024) · Translational Lung Cancer Research · doi:10.21037/tlcr-24-253 · Cited by 4
Almeldin, D. S., Malhotra, J. D., Patel, M. M., Aisner, J., & Jabbour, S. K. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1485 · Cited by 3
Metadata
- Authors
- Smolarz, B., Łukasiewicz, H., Samulak, D., Piekarska, E., Kołaciński, R., & Romanowicz, H.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2025-02-26
- Volume
- 26
- Issue
- 5
- Pages
- 2049
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4407969297
- Cited by
- 259
- References
- 122
- FWCI
- 154.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.